Clinical trialNCT04370587RecruitingPhase 1, PHASE2Interventional

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

SponsorImmVira Pharma Co. LtdEnrollment30HNSCCMelanomaNSCLCSarcomaSolid TumorSquamous Cell Carcinoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Southern Oncology
Bedford Park, Australia
Ganessan Kichenadasse
Recruiting
Peninsula & South Eastern Haematology and Oncology Group
Frankston, Australia
Vinod Ganju
Recruiting
the Alfred
Melbourne, Australia
Andrew Haydon
Recruiting

United States

Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
Completed
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Elizabeth Buchbinder, MD
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Howard Kaufman, MD
Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
John Kirkwood, MD
Recruiting
Mary Crowley Cancer Research
Dallas, Texas, United States
Minal Barve, MD
Recruiting
Virginia Cancer Specialists
Fairfax, Virginia, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Sept 2020
Primary completion: 22 Sept 2026
Completion: 10 Jan 2027
Last update posted: 8 Oct 2025
Registered enrollment: 30
Registry id: NCT04370587

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.